EPZ015666 (GSK3235025) - PRMT5 Inhibitor. CAS# 1616391-65-1 size:10 mg solid (Z)-4-Hydroxytamoxifen: a previously characterised as

(Z)-4-Hydroxytamoxifen: a previously characterised as an Estrogen Receptor antagonist and now found to improve genome-editing specificity

gastric (NUGC-3)

AC-55541 was well absorbed when administered intraperitoneally to rats

CAS Number: 1355324-14-9

correlates with CK2α mRNA and protein levels but not the CK2α' catalytic subunit

EPZ015666 (GSK3235025) - PRMT5 Inhibitor. CAS# 1616391-65-1 size:10 mg solid (Z)-4-Hydroxytamoxifen: a previously characterised asEPZ015666, also known as GSK3235025, CAS No. 1616391 65 1, is a potent and selective and orally active PRMT5 inhibitor with a half maximal inhibitory concentration (IC50) of 22 nM and broad selectivity against a panel of other histone methyltransferases. Treatment of MCL cell lines with EPZ015666 led to inhibition of SmD3 methylation and cell death, with IC50 values in the nanomolar range. Oral dosing with EPZ015666 demonstrated dose dependent